Invention Grant
- Patent Title: Stable formulations of polypeptides and uses thereof
-
Application No.: US13393679Application Date: 2010-09-03
-
Publication No.: US09884117B2Publication Date: 2018-02-06
- Inventor: Ann Brige , Christine Labeur , Marc Jozef Lauwereys
- Applicant: Ann Brige , Christine Labeur , Marc Jozef Lauwereys
- Applicant Address: BE Zwijnaarde
- Assignee: Ablynx N.V.
- Current Assignee: Ablynx N.V.
- Current Assignee Address: BE Zwijnaarde
- Agency: Wolf, Greenfield & Sacks, P.C.
- International Application: PCT/EP2010/062972 WO 20100903
- International Announcement: WO2011/026945 WO 20110310
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07K16/24 ; A61K39/00 ; A61K39/395 ; A61K9/19 ; A61K9/00 ; A61K47/02 ; A61K47/14 ; A61K47/26

Abstract:
Stable formulations are provided that contain immunoglobulin single variable domains at a high concentration. The formulations are useful as pharmaceutical formulation and suitable for subcutaneous administration. The formulations can be transported and stored under various stress conditions. The invention further relates to containers and pharmaceutical units comprising such formulations and to methods for preparing and prophylactic and therapeutic uses of the formulations and pharmaceutical units of the invention.
Public/Granted literature
- US20120201812A1 STABLE FORMULATIONS OF POLYPEPTIDES AND USES THEREOF Public/Granted day:2012-08-09
Information query